Fachliteratur Gastroenterologie: Leber

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber » Anderes

28. August 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3810


	Artikel 1 - 20 / 76197

	Human infestations with Fasciola hepatica in Austria between 1955 and 2025: data from a low-incidence country. Parasite Mikosch P, Trifina-Mikosch E, Schwarz C, Auer H. PMID: 42657804 [PubMed - indexed for MEDLINE]
	Immune-inflammatory biomarkers and immune features in metabolic dysfunction-associated steatotic liver disease: a bibliometric study. Front Immunol Ye Z, Liu M, Wu Q, Wang J, Lyu W. PMID: 42656653 [PubMed - indexed for MEDLINE]
	Metabolic dysfunction-associated steatohepatitis (MASH): intersections with type 2 diabetes and insulin resistance. Front Endocrinol (Lausanne) Giannoukakis N. PMID: 42656283 [PubMed - indexed for MEDLINE]
	Diagnostic BMI and Induction Therapy Weight Change Associated With Hepatotoxicity in Pediatric Patients With Acute Lymphoblastic Leukemia. Cancer Med Mason EJ, Woodhouse JP, Schraw JM, Yi JS, Rabin KR, Gramatges MM, Zobeck MC, Chen B, Harrell MB, Taylor OA, Scheurer ME, Lupo PJ, Huynh V, Mittelman SD, Orgel E, Brown A. PMID: 42655909 [PubMed - indexed for MEDLINE]
	Weight Gain Is Associated with Short-Term FIB-4 Increase and Concurrent Metabolic Change in People with HIV and Metabolic Dysfunction-Associated Steatotic Liver Disease. Viruses Xu W, Liu L, Sun M, Zhang R, Chen J, Shen Y. PMID: 42655713 [PubMed - indexed for MEDLINE]
	The FIB-4 Is a Marker of Monocyte/Macrophage Activation Independently from Severe Hepatic Disease in People Living with HIV on Stable and Successful Treatment. Viruses Vassallo M, Fabre R, Ferrando S, Chirio D, Ameil L, Godemert M, Naqvi A, Cua E, Tuaillon E, Pisoni A, Pradier C, Carles M, Durant J. PMID: 42655649 [PubMed - indexed for MEDLINE]
	Resting Heart Rate as a Physiologic Marker of Steatosis in MASLD: NHANES 2017-2020 Analysis. Medicina (Kaunas) Shamsian E, Mack JR, Mohsen M, Makol A, Rao S, Karkra R, Bebawy M, Maan MHA, Ilyas F, Al-Khazraji A, Gaglio P. PMID: 42654376 [PubMed - indexed for MEDLINE]
	Strategy to Improve Diagnostic Performance of Hepatic Steatosis Grading Using Ultrasound: Combination of Qualitative and Quantitative Approaches. Medicina (Kaunas) Shokirjon Ugli AS, Lee S, Yoon JK, Lee JS, Kim SS. PMID: 42654364 [PubMed - indexed for MEDLINE]
	Independent Associations of Food Insecurity and Neighborhood Deprivation: Independent Associations with Incident Metabolic Dysfunction-Associated Steatotic Liver Disease in a Diverse U.S. Cohort. Nutrients Eun Y, Thearle MS, Kim JH, Trousdale RK, Culpepper-Morgan J. PMID: 42654321 [PubMed - indexed for MEDLINE]
	Protective Effects of Allicin and Garlic-Derived Interventions Against Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Evidence and Mechanistic Insights. Nutrients Sun N, Gao Y, Xing Y, Guo M, Xu X, Hu J, He Z, Luo J, Li S, Hui Z, Zhang S. PMID: 42654176 [PubMed - indexed for MEDLINE]
	Sarcopenia and Frailty in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Impact of Steroid Hormones. Int J Mol Sci Bali T, Lai J, Mourelatou NG, Saridaki A, Tsitsou S, Adamantou M, Kamiliou A, Chologitas C, Sarri M, Pavlopoulou D, Liberopoulos E, Angelousi A, Cholongitas E. PMID: 42653433 [PubMed - indexed for MEDLINE]
	Low-Dose, Long-Term Callistemon citrinus and Its Main Compounds Alter Hepatic Fatty Acid Profiles and Protect Liver Histology in Rats Fed a High-Fat-Sucrose Diet. Int J Mol Sci Ayala-Ruiz LA, García-Calderón AJ, Magaña-Rodríguez OR, Sánchez-Orozco A, López-Rodríguez M, López-Meza JE, Aguilera-Méndez A, Rios-Chavez P. PMID: 42653264 [PubMed - indexed for MEDLINE]
	The Role of Lachnospiraceae in Liver Diseases: Recent Advances and Clinical Application Prospects. Int J Mol Sci Feng J, Wang X, Cao H, Zhang Y, Xu J, Wang G, Zhu X, Deng S. PMID: 42653180 [PubMed - indexed for MEDLINE]
	Beneficial Hepatokines in MASLD/MASH: Therapeutic Potentials and Drug Delivery Challenges. Int J Mol Sci Amatya R, Min KA, Shin MC. PMID: 42653122 [PubMed - indexed for MEDLINE]
	Shifting Public Interest in Liver Health, Hepatotoxic Medications, and Dietary Supplements in Kazakhstan: A Five-Year Google Trends Infodemiology Study. Int J Environ Res Public Health Saparbay J, Burkitbayev Z. PMID: 42652369 [PubMed - indexed for MEDLINE]
	MASLD: Spatial Mechanisms and New Therapeutics. Biomolecules Stoess C, Onyuru J, Hu Y, Jiang Y, Xin Z, Panchal A, Hartmann P. PMID: 42650797 [PubMed - indexed for MEDLINE]
	High Prevalence of Protective HSD17B13 Variant in Taiwan: An Analysis in Morbidly Obese Individuals and Liver Donors. Genes (Basel) Lin HY, Tseng HY, Lin CC, Tzeng WJ, Hou TY, Li WF, Lin YC, Yin SM, Wang CC, Liu YY, Lin YH. PMID: 42650052 [PubMed - indexed for MEDLINE]
	Intervention effects and underlying mechanisms of bioactive components from Citrus species on type 2 diabetes and fatty liver diseases: a mechanistic review. J Pharm Pharmacol Sarkar A, Banerjee T, De A, Paul A, Bhowmik R, Ghosh N, Dewanjee S, Bala A, Karmakar S. PMID: 42647844 [PubMed - indexed for MEDLINE]
	Combined Exposure to Deoxynivalenol and Patulin Aggravates Liver Injury in Mice via Triggering Inflammation, Apoptosis, and Oxidative Stress. Toxins (Basel) Zhao Q, Xu Z, Dai X, Zhang X, Li M, Chang J, Yin Q, Yang G, Liu C. PMID: 42646783 [PubMed - indexed for MEDLINE]
	AI-assisted segmentation-based fusion model integrating deep learning, radiomics, and clinical parameters for identifying coronary heart disease risk in patients with MAFLD. Front Endocrinol (Lausanne) Qi L, Zhang S, Wang B, Yang M, Li Y, Li B, Xue J, Li X. PMID: 42643589 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 76197

Seite 1 von 3810



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung